NL8200458A - Werkwijze voor de bereiding van anti-t-lymfocytenglobuline. - Google Patents
Werkwijze voor de bereiding van anti-t-lymfocytenglobuline. Download PDFInfo
- Publication number
- NL8200458A NL8200458A NL8200458A NL8200458A NL8200458A NL 8200458 A NL8200458 A NL 8200458A NL 8200458 A NL8200458 A NL 8200458A NL 8200458 A NL8200458 A NL 8200458A NL 8200458 A NL8200458 A NL 8200458A
- Authority
- NL
- Netherlands
- Prior art keywords
- cells
- preparation
- globulin
- cell line
- lymphocyte
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
- Y10S530/809—Fused cells, e.g. hybridoma
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/85—Reproductive organs or embryos
- Y10S530/851—Placenta; amniotic fluid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19813105150 DE3105150A1 (de) | 1981-02-12 | 1981-02-12 | Herstellung von anti-t-lymphozyten-globulin. |
| DE3105150 | 1981-02-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8200458A true NL8200458A (nl) | 1982-09-01 |
Family
ID=6124731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8200458A NL8200458A (nl) | 1981-02-12 | 1982-02-05 | Werkwijze voor de bereiding van anti-t-lymfocytenglobuline. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4541953A (fi) |
| AT (1) | AT377698B (fi) |
| AU (1) | AU550257B2 (fi) |
| BE (1) | BE891944A (fi) |
| CA (1) | CA1184491A (fi) |
| CH (1) | CH652410A5 (fi) |
| DE (1) | DE3105150A1 (fi) |
| DK (1) | DK56882A (fi) |
| ES (1) | ES8401982A1 (fi) |
| FI (1) | FI72139C (fi) |
| FR (1) | FR2499413B1 (fi) |
| GB (1) | GB2093037B (fi) |
| HU (1) | HU189998B (fi) |
| IT (1) | IT1195296B (fi) |
| LU (1) | LU83932A1 (fi) |
| NL (1) | NL8200458A (fi) |
| NO (1) | NO157422C (fi) |
| SE (1) | SE460826B (fi) |
| ZA (1) | ZA82905B (fi) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE60233T1 (de) * | 1983-09-15 | 1991-02-15 | Univ Leland Stanford Junior | Allotransplantat mit verminderter immunogenitaet und verfahren und reagenz fuer seine herstellung. |
| US4681760A (en) * | 1985-04-17 | 1987-07-21 | The Board Of Trustees Of The Leland Stanford Junior University | Method of conferring immunotolerance to a specific antigen |
| US5011684A (en) * | 1985-09-05 | 1991-04-30 | Beth Israel Hospital Association | Lysing or blocking unwanted cells with IL-2 receptor-specific binding substance |
| US5785966A (en) * | 1994-06-15 | 1998-07-28 | Coles; John G. | Inhibition of human xenogenic or allogenic antibodies to reduce xenograft or allograft rejection in human recipients |
| FR2878852B1 (fr) * | 2000-09-28 | 2007-02-23 | Imtix Sangstat | Procede de production d'immunoglobulines anti-thymocytes humains |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4363799A (en) * | 1979-03-20 | 1982-12-14 | Ortho Pharmaceutical Corporation | Monoclonal antibody to human T cells, and methods for preparing same |
| US4361549A (en) * | 1979-04-26 | 1982-11-30 | Ortho Pharmaceutical Corporation | Complement-fixing monoclonal antibody to human T cells, and methods of preparing same |
| US4364935A (en) * | 1979-12-04 | 1982-12-21 | Ortho Pharmaceutical Corporation | Monoclonal antibody to a human prothymocyte antigen and methods of preparing same |
| US4364933A (en) * | 1979-12-04 | 1982-12-21 | Ortho Pharmaceutical Corporation | Monoclonal antibody to a human thymocyte antigen and methods of preparing same |
| US4361550A (en) * | 1979-12-04 | 1982-11-30 | Ortho Pharmaceutical Corporation | Complement-fixing monoclonal antibody to human suppressor T cells and methods of preparing same |
-
1981
- 1981-02-12 DE DE19813105150 patent/DE3105150A1/de active Granted
- 1981-11-23 GB GB8135192A patent/GB2093037B/en not_active Expired
- 1981-11-24 IT IT25247/81A patent/IT1195296B/it active
- 1981-12-11 FR FR8123180A patent/FR2499413B1/fr not_active Expired
-
1982
- 1982-01-05 NO NO820014A patent/NO157422C/no unknown
- 1982-01-14 AT AT0011482A patent/AT377698B/de not_active IP Right Cessation
- 1982-01-26 FI FI820233A patent/FI72139C/fi not_active IP Right Cessation
- 1982-01-29 BE BE0/207174A patent/BE891944A/fr not_active IP Right Cessation
- 1982-02-04 SE SE8200639A patent/SE460826B/sv not_active IP Right Cessation
- 1982-02-05 NL NL8200458A patent/NL8200458A/nl not_active Application Discontinuation
- 1982-02-08 CA CA000395714A patent/CA1184491A/en not_active Expired
- 1982-02-10 LU LU83932A patent/LU83932A1/de unknown
- 1982-02-10 DK DK56882A patent/DK56882A/da not_active Application Discontinuation
- 1982-02-11 ES ES509504A patent/ES8401982A1/es not_active Expired
- 1982-02-11 AU AU80373/82A patent/AU550257B2/en not_active Ceased
- 1982-02-11 HU HU82426A patent/HU189998B/hu not_active IP Right Cessation
- 1982-02-12 ZA ZA82905A patent/ZA82905B/xx unknown
- 1982-02-12 CH CH905/82A patent/CH652410A5/de not_active IP Right Cessation
-
1984
- 1984-02-21 US US06/582,030 patent/US4541953A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| LU83932A1 (de) | 1982-07-07 |
| ATA11482A (de) | 1984-09-15 |
| US4541953A (en) | 1985-09-17 |
| DK56882A (da) | 1982-08-13 |
| ES509504A0 (es) | 1984-01-16 |
| SE460826B (sv) | 1989-11-27 |
| NO157422B (no) | 1987-12-07 |
| FR2499413B1 (fr) | 1985-08-30 |
| HU189998B (en) | 1986-08-28 |
| IT8125247A0 (it) | 1981-11-24 |
| SE8200639L (sv) | 1982-08-13 |
| GB2093037B (en) | 1984-07-18 |
| FI72139C (fi) | 1987-04-13 |
| ZA82905B (en) | 1982-12-29 |
| AU8037382A (en) | 1982-08-19 |
| CA1184491A (en) | 1985-03-26 |
| FR2499413A1 (fr) | 1982-08-13 |
| AU550257B2 (en) | 1986-03-13 |
| IT1195296B (it) | 1988-10-12 |
| CH652410A5 (de) | 1985-11-15 |
| DE3105150A1 (de) | 1982-08-19 |
| ES8401982A1 (es) | 1984-01-16 |
| NO820014L (no) | 1982-08-13 |
| DE3105150C2 (fi) | 1989-02-23 |
| FI820233L (fi) | 1982-08-13 |
| BE891944A (fr) | 1982-05-17 |
| GB2093037A (en) | 1982-08-25 |
| NO157422C (no) | 1988-03-16 |
| FI72139B (fi) | 1986-12-31 |
| AT377698B (de) | 1985-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI75183C (fi) | Foerfarande foer framstaellning av en komplement-bindande monoklonal antikropp mot maenniskans t-celler genom anvaendning av en ny hybridcellinje. | |
| US4443427A (en) | Monoclonal antibody | |
| US6129916A (en) | Method of Increasing activation on proliferation of T cells using antibody-microbead conjugates | |
| DE69133326T2 (de) | Verbesserte humanähnlich gemachte immunglobuline | |
| JPH0717519B2 (ja) | α―インターフェロンに対する抗体と複合されたα―インターフェロン治療製剤 | |
| JPH0159867B2 (fi) | ||
| JPH0223156B2 (fi) | ||
| Ramalho‐Pinto et al. | Murine Schistosomiasis mansoni: anti‐schistosomula antibodies and the IgG subclasses involved in the complement‐and eosinophilmediated killing of schistosomula in vitro | |
| FI75598B (fi) | Foerfarande foer framstaellning av en monoklonal antikropp mot en maensklig tymocytantigen medelst en ny hybridcellinje. | |
| JP2013535444A (ja) | 注意欠陥多動性障害を治療する方法 | |
| KR930000188B1 (ko) | 신규 림포카인(lymphokine), 이 림포카인에 특이적인 모노클로날 항체 및 이들의 제조방법 | |
| US4906469A (en) | Appropriate cytotoxic pharmaceutical combination especially for the treatment of cancers | |
| EP1229936B1 (de) | Verwendung von anti-idiotypischen antikörpern als impfstoffe gegen krebs | |
| JPS5939832A (ja) | モノクロ−ナル抗体ならびにその製法、使用法 | |
| JPH03503164A (ja) | 抗‐パンｔ‐細胞イムノトキシン組成物による免疫抑制 | |
| NL8200458A (nl) | Werkwijze voor de bereiding van anti-t-lymfocytenglobuline. | |
| FI115383B (fi) | Menetelmä Anti-inflammatorisen tekijän eristämiseksi | |
| JPH03505211A (ja) | 好酸球増加症の予防または鎮静用薬剤 | |
| JPS6128000A (ja) | ヒトｎｋ細胞溶解可能なモノクロ−ナル抗体 | |
| KR930004596B1 (ko) | 신규 림포킨(lymphokine) 및 이에 대해 특이성을 갖는 모노클로날(monoclonal) 항체의 제조 방법 | |
| Johnson et al. | Antibody-Mediated Suppression of Tumor Growth: I. Suppression by Murine IgG1 Isolated from Alloantiserum | |
| EP0419462A1 (en) | Improved immunotoxin therapies utilizing purified ricin a-chain species | |
| Broder et al. | Characteristics of multiple myeloma as an immunodeficiency disease | |
| DE3919294C2 (de) | Verwendung eines monoklonalen Antikörpers zur Behandlung einer Autoimmunerkrankung | |
| Pathy | Patent Evaluation on Monoclonal Antibody (MAB) Therapy with Binding Specificity to CD20 B-Cell Surface Antigen Bp35 and the Manufacturing Process of Biological & Antibodies and Derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A85 | Still pending on 85-01-01 | ||
| BA | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| BV | The patent application has lapsed |